<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник урологии</journal-title><trans-title-group xml:lang="en"><trans-title>Urology Herald</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2022-10-4-70-78</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-626</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Факторы риска реинфекции у пациентов после дренирования верхних мочевых путей по поводу обструктивного пиелонефрита</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors for re-infection in patients after drainage of the upper urinary tract due to obstructive pyelonephritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5755-5950</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мамаев</surname><given-names>И. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Mamaev</surname><given-names>I. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мамаев Ибрагим Энверович — кандидат медицинских наук, доцент кафедры урологии и андрологии РНИМУ им. Н.И. Пирогова Минздрава России; заведующий урологическим отделением ГКБ имени В.М. Буянова ДЗМ.</p><p>117321, Москва, ул. Островитянова, д. 1; 115516, Москва, ул. Бакинская, д. 26</p></bio><bio xml:lang="en"><p>Ibragim E. Mamaev — M.D., Cand.Sc.(Med), Assoc. Prof. (Docent), Dept. of Urology and An-drology, Pirogov Russian National Research Medical University (Pirogov Medical University); Head, Urology Division, Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department.</p><p>1 Ostrovityanova St., Moscow, 117997; 26 Bakinskaya St., Moscow, 115560</p></bio><email xlink:type="simple">dr.mamaev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0167-4344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алекберов</surname><given-names>Э. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Alekberov</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алекберов Эмиль Мушфигович — клинический ординатор кафедры урологии и андрологии РНИМУ им. Н.И. Пирогова; врач урологического отделения ГКБ имени В.М. Буянова ДЗМ.</p><p>117321, Москва, ул. Островитянова, д. 1; 115516, Москва, ул. Бакинская, д. 26</p></bio><bio xml:lang="en"><p>Emil M. Alekberov — M.D., Resident, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Urologist, Urology Division, Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department.</p><p>1 Ostrovityanova St., Moscow, 117997; 26 Bakinskaya St., Moscow, 115560</p></bio><email xlink:type="simple">alekberov.e.m@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1989-3254</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глинин</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glinin</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глинин Кирилл Игоревич — ассистент кафедры урологии и андрологии РНИМУ им. Н.И. Пирогова; врач урологического отделения ГКБ имени В.М. Буянова ДЗМ.</p><p>117321, Москва, ул. Островитянова, д. 1; 115516, Москва, ул. Бакинская, д. 26</p></bio><bio xml:lang="en"><p>Kirill I. Glinin — M.D., Assist.Prof., Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University); Urologist, Urology Division, Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department.</p><p>1 Ostrovityanova St., Moscow, 117997; 26 Bakinskaya St., Moscow, 115560</p></bio><email xlink:type="simple">glinin.doc@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9130-148X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сайпулаев</surname><given-names>Г. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Saypulaev</surname><given-names>G. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сайпулаев Гаджимурад Шамильевич — врач урологического отделения ГКБ имени В.М. Буянова ДЗМ.</p><p>115516, Москва, ул. Бакинская, д. 26</p></bio><bio xml:lang="en"><p>Gadzhimurad Sh. Saipulaev — M.D., Urologist, Urology Division, Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department.</p><p>26 Bakinskaya St., Moscow, 115560</p></bio><email xlink:type="simple">dr.saipulaev@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3764-6131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Котов Сергей Владиславович — доктор медицинских наук, профессор, заведующий кафедрой урологии и андрологии РНИМУ им. Н.И. Пирогова Минздрава России.</p><p>117321, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Sergey V. Kotov — M.D., Dr.Sc.(Med), Full Prof., Head, Dept. of Urology and Andrology, Pirogov Russian National Research Medical University (Pirogov Medical University).</p><p>1 Ostrovityanova St., Moscow, 117997</p></bio><email xlink:type="simple">urokotov@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им Н.И. Пирогова Минздрава России; Городская Клиническая Больница имени В.М. Буянова Департамента здравоохранения Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University (Pirogov Medical University); Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Городская Клиническая Больница имени В.М. Буянова Департамента здравоохранения Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Buyanov Moscow City Clinical Hospital — Moscow Healthcare Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University (Pirogov Medical University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2022</year></pub-date><volume>10</volume><issue>4</issue><fpage>70</fpage><lpage>78</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мамаев И.Э., Алекберов Э.М., Глинин К.И., Сайпулаев Г.Ш., Котов С.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Мамаев И.Э., Алекберов Э.М., Глинин К.И., Сайпулаев Г.Ш., Котов С.В.</copyright-holder><copyright-holder xml:lang="en">Mamaev I.E., Alekberov E.M., Glinin K.I., Saypulaev G.S., Kotov S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/626">https://www.urovest.ru/jour/article/view/626</self-uri><abstract><sec><title>Введение</title><p>Введение. Реинфекция после дренирования обструктивного пиелонефрита усугубляет послеоперационное течение заболевания и отодвигает срок возможного хирургического вмешательства, направленного на устранение причины обструкции.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Определить долю пациентов, демонстрирующих развитие клинически значимой реинфекции после дренирования верхних мочевых путей по поводу обструктивного пиелонефрита, исследовать связь сроков дренирования с развитием инфекционно-воспалительных осложнений, а также оценить факторы риска развития реинфекции.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведён анализ данных 1022 пациентов, находившихся на стационарном лечении в период с января 2019 года по декабрь 2021 года, которым проведено дренирование верхних мочевых путей по поводу обструктивного пиелонефрита. Раздельно оценены данные у пациентов после нефростомии и стентирования. Проведён ретроспективный анализ времени и частоты развития реинфекции, а также влияние сахарного диабета на повторное развитие пиелонефрита.</p></sec><sec><title>Результаты</title><p>Результаты. Клиническая картина реинфекции за время дренирования развилась у 16 (4,8%) пациентов с нефростомой и 45 (6,5%) пациентов со стентом. В группе нефростомии реинфекция отмечена в течение первых 2-х недель с момента дренирования у четырёх (25%) пациентов, на 3 – 4 неделе — у 11 (69%). В группе стентирования количество больных, имевших инфекционное осложнение в первые две недели составляло 15 (33%), а в последующие две недели достигало 22 (49%). Доля пациентов с сахарным диабетом оказалась выше среди тех, у кого пиелонефрит развился повторно.</p></sec><sec><title>Заключение</title><p>Заключение. Доля пациентов, госпитализированных с клиникой реинфекции после дренирования верхних мочевых путей, составила 6%. Отмечена тенденция к нарастанию числа госпитализаций с рецидивом пиелонефрита на фоне дренажа при сроке дренирования, превышающем 2 недели. Продемонстрирована статистически значимая разница в риске развития реинфекции между 1 – 2 и 3 – 4 неделями дренирования (p &lt; 0,05).</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Reinfection after drainage of obstructive pyelonephritis exacerbates the postoperative course of the disease and delays the possible surgical intervention aimed at eliminating the cause of obstruction.</p></sec><sec><title>Objectives</title><p>Objectives. To determine the percentage of re-infection in patients drained with double-J stent or nephrostomy catheter for obstructive pyelonephritis. To assess the relationship between the timing of drainage removal and development of re-infection. To establish risk factors for the development of re-infection.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Medical records from 1022 patients who were treated from January 2019 to December 2021 and underwent drainage for obstructive pyelonephritis. The data in patients after nephrostomy and stenting were evaluated separately. A retrospective analysis of the time and frequency of the development of re-infection, as well as the effect of diabetes mellitus on pyelonephritis relapse, was carried out.</p></sec><sec><title>Results</title><p>Results. Re-infection during drainage developed in 16 (4.8%) patients with a nephrostomy and 45 (6.5%) patients with a stent. Among those who had re-infection in the nephrostomy-group, 4 (25.0%) patients noted it within two weeks from the moment of drainage, and 11 (69.0%) at three-four weeks. In the stent-group, the number of patients who had a complication during the first two weeks was 15 (33.0%), and it was 22 (49.0%) during the next two weeks, The proportion of patients with diabetes mellitus was higher among those who developed pyelonephritis again.</p></sec><sec><title>Conclusion</title><p>Conclusion. The percentage of patients hospitalized with clinical re-infection after drainage of the upper urinary tract was 6.0%. There was an increase in the number of hospitalizations with recurrent pyelonephritis in cases where the drainage period lasted more than two weeks (p &lt; 0.05).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>пиелонефрит</kwd><kwd>обструктивный пиелонефрит</kwd><kwd>стентирование</kwd><kwd>нефростомия</kwd><kwd>реинфекция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pyelonephritis</kwd><kwd>obstructive</kwd><kwd>stenting</kwd><kwd>nephrostomy</kwd><kwd>re-infection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016;196(4):1153-60. https://doi.org/10.1016/j.juro.2016.05.090</mixed-citation><mixed-citation xml:lang="en">Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016;196(4):1153-60. https://doi.org/10.1016/j.juro.2016.05.090</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kehinde EO, Al-Awadi KA, Tawheed A, Al-Hunayan A, Ali Y, Mahmoud AH. Factors affecting the fate of prolonged forgotten 'J' stents. Scand J Urol Nephrol. 2001;35(3):222-7. https://doi.org/10.1080/003655901750292006</mixed-citation><mixed-citation xml:lang="en">Kehinde EO, Al-Awadi KA, Tawheed A, Al-Hunayan A, Ali Y, Mahmoud AH. Factors affecting the fate of prolonged forgotten 'J' stents. Scand J Urol Nephrol. 2001;35(3):222-7. https://doi.org/10.1080/003655901750292006</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shabeena KS, Bhargava R, Manzoor MAP, Mujeeburahiman M. Characteristics of bacterial colonization after indwelling double-J ureteral stents for different time duration. Urol Ann. 2018;10(1):71-75. https://doi.org/10.4103/UA.UA_158_17</mixed-citation><mixed-citation xml:lang="en">Shabeena KS, Bhargava R, Manzoor MAP, Mujeeburahiman M. Characteristics of bacterial colonization after indwelling double-J ureteral stents for different time duration. Urol Ann. 2018;10(1):71-75. https://doi.org/10.4103/UA.UA_158_17</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zumstein V, Betschart P, Buhmann MT, Albrich WC, Nolte O, Güsewell S, Engeler DS, Schmid HP, Ren Q, Abt D. Detection of microbial colonization of the urinary tract of patients prior to secondary ureterorenoscopy is highly variable between different types of assessment: results of a prospective observational study. Biofouling. 2019;35(10):1083-1092. https://doi.org/10.1080/08927014.2019.1692000</mixed-citation><mixed-citation xml:lang="en">Zumstein V, Betschart P, Buhmann MT, Albrich WC, Nolte O, Güsewell S, Engeler DS, Schmid HP, Ren Q, Abt D. Detection of microbial colonization of the urinary tract of patients prior to secondary ureterorenoscopy is highly variable between different types of assessment: results of a prospective observational study. Biofouling. 2019;35(10):1083-1092. https://doi.org/10.1080/08927014.2019.1692000</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hanna B, Zhuo K, Chalasani V, Vass J, Rasiah K, Wines M, Vaux K, Chung A. Association between ureteric stent dwell time and urinary tract infection. ANZ J Surg. 2021;91(1-2):187-191. https://doi.org/10.1111/ans.16414</mixed-citation><mixed-citation xml:lang="en">Hanna B, Zhuo K, Chalasani V, Vass J, Rasiah K, Wines M, Vaux K, Chung A. Association between ureteric stent dwell time and urinary tract infection. ANZ J Surg. 2021;91(1-2):187-191. https://doi.org/10.1111/ans.16414</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Szvalb AD, El Haddad H, Rolston KV, Sabir SH, Jiang Y, Raad II, Viola GM. Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection. 2019;47(2):239-245. https://doi.org/10.1007/s15010-018-1245-y</mixed-citation><mixed-citation xml:lang="en">Szvalb AD, El Haddad H, Rolston KV, Sabir SH, Jiang Y, Raad II, Viola GM. Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection. 2019;47(2):239-245. https://doi.org/10.1007/s15010-018-1245-y</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshimura K, Utsunomiya N, Ichioka K, Ueda N, Matsui Y, Terai A. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005;173(2):458-62. https://doi.org/10.1097/01.ju.0000150512.40102.bb</mixed-citation><mixed-citation xml:lang="en">Yoshimura K, Utsunomiya N, Ichioka K, Ueda N, Matsui Y, Terai A. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005;173(2):458-62. https://doi.org/10.1097/01.ju.0000150512.40102.bb</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Swonke ML, Mahmoud AM, Farran EJ, Dafashy TJ, Kerr PS, Kosarek CD, Sonstein J. Early Stone Manipulation in Urinary Tract Infection Associated with Obstructing Nephrolithiasis. Case Rep Urol. 2018;2018:2303492. https://doi.org/10.1155/2018/2303492</mixed-citation><mixed-citation xml:lang="en">Swonke ML, Mahmoud AM, Farran EJ, Dafashy TJ, Kerr PS, Kosarek CD, Sonstein J. Early Stone Manipulation in Urinary Tract Infection Associated with Obstructing Nephrolithiasis. Case Rep Urol. 2018;2018:2303492. https://doi.org/10.1155/2018/2303492</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shi YF, Li WG, Zhang J, Xia SJ, Sun XW. [Effect of double-J stent indwelling time in treatment of ureteric calculi complicated with infection]. Zhonghua Yi Xue Za Zhi. 2016;96(32):2588-91. (In Chinese) https://doi.org/10.3760/cma.j.issn.0376-2491.2016.32.015</mixed-citation><mixed-citation xml:lang="en">Shi YF, Li WG, Zhang J, Xia SJ, Sun XW. [Effect of double-J stent indwelling time in treatment of ureteric calculi complicated with infection]. Zhonghua Yi Xue Za Zhi. 2016;96(32):2588-91. (In Chinese) https://doi.org/10.3760/cma.j.issn.0376-2491.2016.32.015</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Itami Y, Miyake M, Owari T, Iwamoto T, Gotoh D, Momose H, Fujimoto K, Hirao S. Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study. BMC Urol. 2021;21(1):10. https://doi.org/10.1186/s12894-020-00754-8</mixed-citation><mixed-citation xml:lang="en">Itami Y, Miyake M, Owari T, Iwamoto T, Gotoh D, Momose H, Fujimoto K, Hirao S. Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study. BMC Urol. 2021;21(1):10. https://doi.org/10.1186/s12894-020-00754-8</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kord E, Siegel Y, Cooper A, Hirsh S, Goltsman G, Zisman A. Risk factors for re‐infection in patients drained with DJ stent for ureterolithiasis and sepsis. J Urol. 2017;197(4S):e1006. https://doi.org/10.1016/j.juro.2017.02.2157</mixed-citation><mixed-citation xml:lang="en">Kord E, Siegel Y, Cooper A, Hirsh S, Goltsman G, Zisman A. Risk factors for re‐infection in patients drained with DJ stent for ureterolithiasis and sepsis. J Urol. 2017;197(4S):e1006. https://doi.org/10.1016/j.juro.2017.02.2157</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008;5(11):598-608. https://doi.org/10.1038/ncpuro1231</mixed-citation><mixed-citation xml:lang="en">Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008;5(11):598-608. https://doi.org/10.1038/ncpuro1231</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Gabi M, Hefermehl L, Lukic D, Zahn R, Vörös J, Eberli D. Electrical microcurrent to prevent conditioning film and bacterial adhesion to urological stents. Urol Res. 2011;39(2):81-8. https://doi.org/10.1007/s00240-010-0284-3</mixed-citation><mixed-citation xml:lang="en">Gabi M, Hefermehl L, Lukic D, Zahn R, Vörös J, Eberli D. Electrical microcurrent to prevent conditioning film and bacterial adhesion to urological stents. Urol Res. 2011;39(2):81-8. https://doi.org/10.1007/s00240-010-0284-3</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kehinde EO, Rotimi VO, Al-Awadi KA, Abdul-Halim H, Boland F, Al-Hunayan A, Pazhoor A. Factors predisposing to urinary tract infection after J ureteral stent insertion. J Urol. 2002;167(3):1334-7. PMID: 11832726</mixed-citation><mixed-citation xml:lang="en">Kehinde EO, Rotimi VO, Al-Awadi KA, Abdul-Halim H, Boland F, Al-Hunayan A, Pazhoor A. Factors predisposing to urinary tract infection after J ureteral stent insertion. J Urol. 2002;167(3):1334-7. PMID: 11832726</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Coskun AK, Harlak A, Ozer T, Eyitilen T, Yigit T, Demirbaş S, Uzar Aİ, Kozak O, Cetiner S. Is removal of the stent at the end of 2 weeks helpful to reduce infectious or urologic complications after renal transplantation? Transplant Proc. 2011;43(3):813-5. https://doi.org/10.1016/j.transproceed.2010.11.016</mixed-citation><mixed-citation xml:lang="en">Coskun AK, Harlak A, Ozer T, Eyitilen T, Yigit T, Demirbaş S, Uzar Aİ, Kozak O, Cetiner S. Is removal of the stent at the end of 2 weeks helpful to reduce infectious or urologic complications after renal transplantation? Transplant Proc. 2011;43(3):813-5. https://doi.org/10.1016/j.transproceed.2010.11.016</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kord E, Siegel YI, Goltsman G, Hirsh S, Zisman A. Risk factors for recurrent infection in patients drained with a DJ stent for ureterolithiasis and sepsis. J Urol. 2019;201(4S):е172. https://doi.org/10.1097/01.JU.0000555203.51979.44</mixed-citation><mixed-citation xml:lang="en">Kord E, Siegel YI, Goltsman G, Hirsh S, Zisman A. Risk factors for recurrent infection in patients drained with a DJ stent for ureterolithiasis and sepsis. J Urol. 2019;201(4S):е172. https://doi.org/10.1097/01.JU.0000555203.51979.44</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
